SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905718-21-000041
Filing Date
2021-01-11
Accepted
2021-01-11 16:32:37
Documents
1
Period of Report
2020-12-30

Document Format Files

Seq Description Document Type Size
1 pdlbiopharm_fm3dec302020.html 3  
1 pdlbiopharm_fm3dec302020.xml 3 3190
  Complete submission text file 0000905718-21-000041.txt   4895
Mailing Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521
Business Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 900 LARKSPUR LANDING CIRCLE, SUITE 165 LARKSPUR CA 94939
Business Address 900 LARKSPUR LANDING CIRCLE, SUITE 165 LARKSPUR CA 94939 (415) 524-2902
Park West Asset Management LLC (Reporting) CIK: 0001386928 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-19756 | Film No.: 21521178